PMC:7408073 / 31582-31755 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T204","span":{"begin":63,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A204","pred":"fma_id","subj":"T204","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T65","span":{"begin":63,"end":67},"obj":"Body_part"},{"id":"T66","span":{"begin":169,"end":172},"obj":"Body_part"}],"attributes":[{"id":"A65","pred":"uberon_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A66","pred":"uberon_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1164","span":{"begin":4,"end":12},"obj":"Gene"},{"id":"1165","span":{"begin":14,"end":18},"obj":"Gene"},{"id":"1166","span":{"begin":39,"end":58},"obj":"Disease"},{"id":"1167","span":{"begin":99,"end":106},"obj":"Disease"}],"attributes":[{"id":"A1164","pred":"tao:has_database_id","subj":"1164","obj":"Gene:284"},{"id":"A1165","pred":"tao:has_database_id","subj":"1165","obj":"Gene:116511"},{"id":"A1166","pred":"tao:has_database_id","subj":"1166","obj":"MESH:D006331"},{"id":"A1167","pred":"tao:has_database_id","subj":"1167","obj":"MESH:D000860"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T381","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T382","span":{"begin":63,"end":67},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T383","span":{"begin":140,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T384","span":{"begin":157,"end":161},"obj":"http://www.ebi.ac.uk/efo/EFO_0001410"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T283","span":{"begin":4,"end":7},"obj":"Chemical"},{"id":"T284","span":{"begin":169,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A283","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A284","pred":"chebi_id","subj":"T284","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}

{"project":"LitCovid-sentences","denotations":[{"id":"T149","span":{"begin":0,"end":173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T57","span":{"begin":99,"end":106},"obj":"Phenotype"}],"attributes":[{"id":"A57","pred":"hp_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/HP_0012418"}],"text":"(6) Ang (1–7)/MasR pathway can produce cardiac dysfunction and lung alteration leading to systemic hypoxia, which, in turn, upregulates the activity of both arms of the RAS."}